Explore more publications!

Texas Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.

Press releases published on October 20, 2025

Cycurion, Inc. Announces Nasdaq Delisting Determination Letter
Lirum Therapeutics Announces FDA “Study May Proceed” Letter Enabling Inclusion of LX-101 in the RAPID Platform Clinical Trial for Ewing Sarcoma and Desmoplastic Small Round Cell Tumor
Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder
La FDA autorise le système d’implant de pied et de cheville SINAPTIC® de SINTX Technologies
SINTX Technologies מקבלת אישור FDA לטכנולוגיית השתלת כף רגל וקרסול SINAPTIC®
SINTX Technologies erhält FDA-Zulassung für SINAPTIC® Fuß- und Sprunggelenk-Implantatsystem
SINTX Technologies obtiene aprobación de la FDA para el sistema de implantes SINAPTIC® para pie y tobillo
SINTX Technologies Mendapatkan Persetujuan dari FDA untuk Sistem Implan Kaki dan Pergelangan Kaki SINAPTIC®
シントクス・テクノロジーズ (SINTX Technologies)、SINAPTIC®足・足首用インプラントシステムでFDA認可を取得
SINTX 테크놀로지스, SINAPTIC® 발·발목 임플란트 시스템에 대해 FDA 승인 획득
SINTX Technologies ได้รับการรับรองจาก FDA สำหรับระบบปลูกถ่ายเท้าและข้อเท้า SINAPTIC®
SINTX Technologies 的 SINAPTIC® 足踝植入系统获得 FDA 上市许可
SINTX Technologies 獲 FDA 批准 SINAPTIC® 足踝植入系統
SINTX Technologies Menerima Kelulusan FDA untuk SINAPTIC® Foot & Ankle Implant System
SINTX Technologies Recebe Autorização da FDA para Sistema de Implantes de Pé e Tornozelo SINAPTIC®
Mobile Infrastructure to Participate in 2025 Maxim Growth Summit on October 23
Verrica Pharmaceuticals Receives Positive Feedback from the European Medicines Agency (EMA) Supporting a Clear Regulatory Path Forward to File for Approval of YCANTH® in the European Union
CytomX Therapeutics Appoints Rachael Lester as Chief Business Officer
HeartCore to Authorize One-Time Dividend Payment
CarGurus To Report Third Quarter 2025 Financial Results

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions